galactose has been researched along with Amentia in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (18.18) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Chaturbhuj, SG; Das, M; Gourishetti, K; Kanojia, U; Kishore, A; Krishnadas, N; Nayak, PG; Sankhe, R; Surubhotla, R | 1 |
Attia, A; El-Shenawy, S; Gomaa, N; Hassan, A; Hegazy, R; Kenawy, S; Zaki, H | 1 |
Chattipakorn, N; Chattipakorn, SC; Pratchayasakul, W; Shwe, T | 1 |
Feng, GF; Han, H; Hu, XD; Liu, Y; Qian, YH; Shi, LL; Yang, WN | 1 |
Dubovický, M; Kašparová, S; Kucharská, J; Liptaj, T; Lipták, B; Sumbalová, Z; Szomolányi, P; Trattnig, S; Tušková, R; Uličná, O; Vančová, O | 1 |
Bagheri, SM; Dashti-R, MH | 1 |
Cui, X; Hu, Y; Li, X; Liu, J; Long, J; Packer, L; Zhang, Q; Zuo, P | 1 |
Hong, Y; Long, MS; Yang, Y; Zhou, XH | 1 |
Fang, F; Liu, G | 1 |
KATZMAN, R; KOREY, SR; SUZUKI, K | 1 |
Brackenridge, CJ | 1 |
1 review(s) available for galactose and Amentia
Article | Year |
---|---|
Role of D-galactose-induced brain aging and its potential used for therapeutic interventions.
Topics: Aging; Brain; Cellular Senescence; Cognition; Dementia; Drug Discovery; Galactose; Humans; Mitochondria; Models, Animal | 2018 |
10 other study(ies) available for galactose and Amentia
Article | Year |
---|---|
Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction.
Topics: Aging; Aluminum Chloride; Animals; Cognitive Dysfunction; Dementia; Disease Models, Animal; Galactose; Hippocampus; Lipid Peroxidation; Male; Maze Learning; Mitochondrial Diseases; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Polycyclic Sesquiterpenes; Rats; Rats, Sprague-Dawley | 2021 |
Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin.
Topics: Adamantane; Aging; Animals; Biomarkers; Body Weight; Brain; Dementia; Dipeptides; Galactose; Glycated Hemoglobin; Hypoglycemic Agents; Insulin Resistance; Locomotion; Male; Metformin; Nerve Tissue Proteins; Oxidative Stress; Rats; Rats, Wistar; Reaction Time | 2017 |
The effects of valsartan on cognitive deficits induced by aluminum trichloride and d-galactose in mice.
Topics: Acetylcholinesterase; Aluminum Chloride; Aluminum Compounds; Animals; Cerebral Cortex; Chlorides; Cognition Disorders; Dementia; Disease Models, Animal; Galactose; Glutathione Peroxidase; Hippocampus; Malondialdehyde; Maze Learning; Memory Disorders; Mice; Nootropic Agents; Oxidative Stress; Random Allocation; Superoxide Dismutase; Tetrazoles; Valine; Valsartan | 2014 |
Neuronal marker recovery after Simvastatin treatment in dementia in the rat brain: in vivo magnetic resonance study.
Topics: Animals; Aspartic Acid; Biomarkers; Brain; Dementia; Dipeptides; Disease Models, Animal; Galactose; Inositol; Magnetic Resonance Spectroscopy; Male; Nootropic Agents; Organ Size; Phosphorus Isotopes; Protons; Rats, Wistar; Simvastatin; Spatial Learning; Spatial Memory; Thiobarbituric Acid Reactive Substances; Treatment Outcome; Ubiquinone | 2015 |
Influence of asafoetida on prevention and treatment of memory impairment induced by d-galactose and NaNO2 in mice.
Topics: Animals; Behavior, Animal; Dementia; Disease Models, Animal; Ferula; Food Preservatives; Galactose; Iran; Memory Disorders; Mice; Phytotherapy; Plant Preparations; Sodium Nitrite | 2015 |
Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid.
Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Caspases; Dementia; Disease Models, Animal; Galactose; Glutathione Peroxidase; Hippocampus; Male; Malondialdehyde; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Superoxide Dismutase; Thioctic Acid | 2006 |
[Anti-dementia effects of grape peel extracts experiment study].
Topics: Animals; Dementia; Free Radical Scavengers; Galactose; Male; Neuroprotective Agents; Nitrates; Plant Extracts; Random Allocation; Rats; Rats, Wistar; Vitis | 2006 |
A novel cyclic squamosamide analogue compound FLZ improves memory impairment in artificial senescence mice induced by chronic injection of D-galactose and NaNO2.
Topics: Administration, Oral; Aging; Animals; Annona; Benzeneacetamides; Blotting, Western; Dementia; Dose-Response Relationship, Drug; Galactose; Gene Expression Regulation; Glutathione Peroxidase; Hippocampus; Male; Malondialdehyde; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Microscopy; Phenols; Proto-Oncogene Proteins c-bcl-2; Sodium Nitrite; Superoxide Dismutase; Time Factors | 2007 |
CHEMICAL STUDIES ON ALZHEIMER'S DISEASE.
Topics: Alzheimer Disease; Amino Acids; Brain Chemistry; Carbon Isotopes; Cerebrosides; Cholesterol; Chromatography; Dementia; Electrophoresis; Gangliosides; Glucose; Hexosamines; Hexoses; Humans; Lipid Metabolism; Nerve Tissue Proteins; Neuraminic Acids; Phospholipids; Polysaccharides; Psychotic Disorders | 1965 |
The fractionation of some plasma constituents by exclusion chromatography, with application to neuropsychiatric disorders.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Proteins; Brain Diseases; Cerebrospinal Fluid Proteins; Child; Child, Preschool; Chromatography, Gel; Dementia; Female; Hexoses; Humans; Huntington Disease; Hydrogen-Ion Concentration; Male; Mathematics; Mental Disorders; Methods; Molecular Weight; Parietal Lobe; Psychotic Disorders; Schizophrenia | 1970 |